Avatrombopag maleate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for avatrombopag maleate and what is the scope of freedom to operate?
Avatrombopag maleate
is the generic ingredient in one branded drug marketed by Akarx Inc and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Avatrombopag maleate has twenty-one patent family members in fourteen countries.
Summary for avatrombopag maleate
International Patents: | 21 |
US Patents: | 3 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Clinical Trials: | 4 |
Patent Applications: | 8 |
What excipients (inactive ingredients) are in avatrombopag maleate? | avatrombopag maleate excipients list |
DailyMed Link: | avatrombopag maleate at DailyMed |
Recent Clinical Trials for avatrombopag maleate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Chinese PLA General Hospital | Phase 4 |
Eisai Inc. | Phase 3 |
Eisai Inc. | Phase 2 |
US Patents and Regulatory Information for avatrombopag maleate
International Patents for avatrombopag maleate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2416304 | See Plans and Pricing | |
Japan | 4120586 | See Plans and Pricing | |
Denmark | 1466912 | See Plans and Pricing | |
Japan | 2008111001 | 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF | See Plans and Pricing |
Japan | 4844574 | See Plans and Pricing | |
Netherlands | 301020 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for avatrombopag maleate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1466912 | 19C1072 | France | See Plans and Pricing | PRODUCT NAME: AVATROMBOPAG ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, EN PARTICULIER L'AVATROMBOPAG MALEATE; NAT. REGISTRATION NO/DATE: EU/1/19/1373 20190624; FIRST REGISTRATION: IE - EU/1/19/1373 20190624 |
1466912 | 58/2019 | Austria | See Plans and Pricing | PRODUCT NAME: AVATROMBOPAG ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON, INSBESONDERE AVATROMBOPAGMALEAT; REGISTRATION NO/DATE: EU/1/19/1373 (MITTEILUNG) 20190624 |
1466912 | 1990057-0 | Sweden | See Plans and Pricing | PRODUCT NAME: AVATROMBOPAG, AND PHYSIOLOGICAL SALTS THEREOF, INCLUDING AVATROMBOPAG MALEATE; REG. NO/DATE: EU/1/19/1373 20190624 |
1466912 | SPC/GB19/071 | United Kingdom | See Plans and Pricing | PRODUCT NAME: AVATROMBOPAG MALEATE; REGISTERED: UK EU/1/19/1373/001-002 20190624; UK EXTRA MA'S ON IPSUM 20190624 |
1466912 | 341 50024-2019 | Slovakia | See Plans and Pricing | PRODUCT NAME: AVATROMBOPAG VO VSETKYCH FORMACH CHRANENYCH ZA- KLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/19/1373 20190624 |
1466912 | 2019/058 | Ireland | See Plans and Pricing | PRODUCT NAME: AVATROMBOPAG OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR AVATROMBOPAG MALEATE; REGISTRATION NO/DATE: EU/1/19/1373 20190624 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |